Paper25601901
Notching on Cancer's Door: Notch Signaling in Brain Tumors.
Teodorczyk M and 1 other. Front Oncol, 2014. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Notching on Cancer's Door: Notch Signaling in Brain Tumors. Papers, record 25601901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25601901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References193
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11257223 | EGF receptor and Notch signaling act upstream of Eyeless/Pax6 to control eye specification. | Cell | 2001 | https://conductscience.org/library/papers/11257223 | PubMed |
| 2 | 12794186 | The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12794186 | PubMed |
| 3 | 7566092 | Signalling downstream of activated mammalian Notch. | Nature | 1995 | https://conductscience.org/library/papers/7566092 | PubMed |
| 4 | 9528780 | NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9528780 | PubMed |
| 5 | 11545715 | Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. | Neuron | 2001 | https://conductscience.org/library/papers/11545715 | PubMed |
| 6 | 22445247 | A phase II study of RO4929097 in metastatic colorectal cancer. | Eur J Cancer | 2012 | https://conductscience.org/library/papers/22445247 | PubMed |
| 7 | 10940313 | Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10940313 | PubMed |
| 8 | 17028337 | Structure-function analysis of delta trafficking, receptor binding and signaling in Drosophila. | Genetics | 2006 | https://conductscience.org/library/papers/17028337 | PubMed |
| 9 | 17217625 | Notch signaling enhances nestin expression in gliomas. | Neoplasia | 2006 | https://conductscience.org/library/papers/17217625 | PubMed |
| 10 | 9244302 | Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. | Cell | 1997 | https://conductscience.org/library/papers/9244302 | PubMed |
| 11 | 10551863 | Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10551863 | PubMed |
| 12 | 22991436 | Ectodomain shedding and ADAMs in development. | Development | 2012 | https://conductscience.org/library/papers/22991436 | PubMed |
| 13 | 1831692 | TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. | Cell | 1991 | https://conductscience.org/library/papers/1831692 | PubMed |
| 14 | 8681805 | Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. | Development | 1996 | https://conductscience.org/library/papers/8681805 | PubMed |
| 15 | 20736377 | Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. | Cancer Res | 2010 | https://conductscience.org/library/papers/20736377 | PubMed |
| 16 | 24668033 | A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma. | Invest New Drugs | 2014 | https://conductscience.org/library/papers/24668033 | PubMed |
| 17 | 16103883 | Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. | Oncogene | 2005 | https://conductscience.org/library/papers/16103883 | PubMed |
| 18 | 9221780 | Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. | J Neurosci | 1997 | https://conductscience.org/library/papers/9221780 | PubMed |
| 19 | 23945239 | Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23945239 | PubMed |
| 20 | 21184132 | CD133+ niches and single cells in glioblastoma have different phenotypes. | J Neurooncol | 2011 | https://conductscience.org/library/papers/21184132 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42405342 | What role does the Notch signaling pathway play in exercise-related metabolic and neurological adaptations? A molecular-to-systems perspective. | Front Physiol | 2026 | https://conductscience.org/library/papers/42405342 | PubMed |
| 41664583 | Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets. | Cell Prolif | 2026 | https://conductscience.org/library/papers/41664583 | PubMed |
| 40935208 | Role of Notch and its oncogenic signaling crosstalk in glioma and glioma stem cells. | Gene | 2025 | https://conductscience.org/library/papers/40935208 | PubMed |
| 40694161 | Natural bioactive compounds as notch signaling modulators: cutting-edge strategies for cancer therapy. | Med Oncol | 2025 | https://conductscience.org/library/papers/40694161 | PubMed |
| 39394529 | γ-Glutamylcyclotransferase is transcriptionally regulated by c-Jun and controls proliferation of glioblastoma stem cells through Notch1 levels. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/39394529 | PubMed |
| 38906903 | NOTCH3 as a prognostic biomarker and its correlation with immune infiltration in gastrointestinal cancers. | Sci Rep | 2024 | https://conductscience.org/library/papers/38906903 | PubMed |
| 38321118 | Gliomas: a reflection of temporal gliogenic principles. | Commun Biol | 2024 | https://conductscience.org/library/papers/38321118 | PubMed |
| 37628760 | Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628760 | PubMed |
| 37605966 | NOTCH signalling - a core regulator of bile duct disease? | Dis Model Mech | 2023 | https://conductscience.org/library/papers/37605966 | PubMed |
| 36660663 | MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36660663 | PubMed |
| 36627893 | Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance. | Cancer Drug Resist | 2022 | https://conductscience.org/library/papers/36627893 | PubMed |
| 36314076 | Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells. | Cancer Sci | 2023 | https://conductscience.org/library/papers/36314076 | PubMed |
| 36282125 | Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. | FEBS Open Bio | 2023 | https://conductscience.org/library/papers/36282125 | PubMed |
| 35642785 | Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth. | Elife | 2022 | https://conductscience.org/library/papers/35642785 | PubMed |
| 35563449 | Tumour Stem Cells in Breast Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563449 | PubMed |
| 35408894 | Modulation of Notch Signaling Pathway by Bioactive Dietary Agents. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35408894 | PubMed |
| 35204054 | Molecular Mechanisms and Clinical Challenges of Glioma Invasion. | Brain Sci | 2022 | https://conductscience.org/library/papers/35204054 | PubMed |
| 35112158 | Identification of vascular cues contributing to cancer cell stemness and function. | Angiogenesis | 2022 | https://conductscience.org/library/papers/35112158 | PubMed |
| 35054871 | Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35054871 | PubMed |
| 35018234 | A Notch inhibitor plus Resveratrol induced blockade of autophagy drives glioblastoma cell death by promoting a switch to apoptosis. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/35018234 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25601901
GET https://conductscience.org/api/papers/v1/25601901/references?page=2